Cerevel Therapeutics Hldg
(NASDAQ:CERE)
$42.56
0.23[0.54%]
At close: Mar 18
$42.56
0[0.00%]
After Hours: 4:03PM EDT

GET A REPORT ON CERE SENT RIGHT TO YOUR INBOX

Cerevel Therapeutics Hldg Stock (NASDAQ:CERE), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Neutral
Highest Price Target1
$54.00
Lowest Price Target1
$22.00
Consensus Price Target1
$38.13

Analyst Rating Summary1

Analyst Ratings
Sep 23
1
Nov 23
1
1
Dec 23
5
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Mizuho
JP Morgan
Jefferies
TD Cowen
HC Wainwright & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Cerevel Therapeutics Hldg

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/16/2024CEREBuy Now
Cerevel Therapeutics Hldg
$42.565.73%Mizuho
Graig Suvannavejh
$25 → $45MaintainsNeutralGet Alert
12/28/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.565.73%JP Morgan
Jessica Fye
$25 → $45MaintainsNeutralGet Alert
12/22/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.565.73%Jefferies
Michael Yee
$40 → $45DowngradeBuy → HoldGet Alert
12/08/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.565.73%TD Cowen
Joseph Thome
→ $45DowngradeOutperform → Market PerformGet Alert
12/07/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.565.73%HC Wainwright & Co.
Douglas Tsao
$41 → $45DowngradeBuy → NeutralGet Alert
12/07/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.565.73%Piper Sandler
David Amsellem
$33 → $45DowngradeOverweight → NeutralGet Alert
12/07/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.565.73%Cantor Fitzgerald
Charles Duncan
$38 → $45DowngradeOverweight → NeutralGet Alert
11/20/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-41.26%JP Morgan
Jessica Fye
→ $25Reinstates → NeutralGet Alert
11/02/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-10.71%Morgan Stanley
Matthew Harrison
$42 → $38MaintainsOverweightGet Alert
09/28/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-22.46%Piper Sandler
David Amsellem
→ $33Initiates → OverweightGet Alert
08/07/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-41.26%Mizuho
Graig Suvannavejh
$29 → $25MaintainsNeutralGet Alert
08/03/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-1.32%Morgan Stanley
Matthew Harrison
$46 → $42MaintainsOverweightGet Alert
08/03/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-27.16%B of A Securities
Tazeen Ahmad
$36 → $31DowngradeBuy → NeutralGet Alert
08/03/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-3.67%HC Wainwright & Co.
Douglas Tsao
$45 → $41MaintainsBuyGet Alert
05/23/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-29.51%Goldman Sachs
Madhu Kumar
$31 → $30MaintainsNeutralGet Alert
05/08/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-31.86%Mizuho
Graig Suvannavejh
$26 → $29MaintainsNeutralGet Alert
05/04/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56-29.51%Wells Fargo
Mohit Bansal
→ $30UpgradeEqual-Weight → OverweightGet Alert
04/10/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.56TD Cowen
Joseph Thome
Initiates → OutperformGet Alert
04/03/2023CEREBuy Now
Cerevel Therapeutics Hldg
$42.565.73%HC Wainwright & Co.
Douglas Tsao
→ $45Reiterates → BuyGet Alert

FAQ

Q

What is the target price for Cerevel Therapeutics Hldg (CERE)?

A

The latest price target for Cerevel Therapeutics Hldg (NASDAQ: CERE) was reported by Mizuho on February 16, 2024. The analyst firm set a price target for $45.00 expecting CERE to rise to within 12 months (a possible 5.73% upside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cerevel Therapeutics Hldg (CERE)?

A

The latest analyst rating for Cerevel Therapeutics Hldg (NASDAQ: CERE) was provided by Mizuho, and Cerevel Therapeutics Hldg maintained their neutral rating.

Q

When is the next analyst rating going to be posted or updated for Cerevel Therapeutics Hldg (CERE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cerevel Therapeutics Hldg, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cerevel Therapeutics Hldg was filed on February 16, 2024 so you should expect the next rating to be made available sometime around February 16, 2025.

Q

Is the Analyst Rating Cerevel Therapeutics Hldg (CERE) correct?

A

While ratings are subjective and will change, the latest Cerevel Therapeutics Hldg (CERE) rating was a maintained with a price target of $25.00 to $45.00. The current price Cerevel Therapeutics Hldg (CERE) is trading at is $42.56, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch